Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

INTRODUCTION: Combination therapy with both basal insulin (BI) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is an effective treatment in patients with uncontrolled type 2 diabetes mellitus (T2DM). The recent development and release of a fixed-ratio combination of slow-release insulin deg...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Ther
Main Authors: Zenari, Luciano, Da Porto, Andrea, De Moliner, Lorena, Lugli, Francesca, Guazzoni, Valeria, Groppelli, Gloria, Molteni, Laura, Bracaccia, Massimo, Frison, Vera, Simioni, Natalino, Bonsembiante, Barbara, Miranda, Cesare, Lapolla, Annunziata
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843811/
https://ncbi.nlm.nih.gov/pubmed/33104959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00945-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares